Latest Ratios: P/E Ratio -0.1x · EV/EBITDA N/A · ROE -203.6%. (2012–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $14M | $12M | $303M | $68M | $13M | $2M | $1M | $92M | $12M | $367920 | $49M |
| Enterprise Value | $14M | $12M | $288M | $49M | $4M | $-31752553 | $-15379159 | $33M | $-60460032 | $-16482080 | $5M |
| P/E Ratio → | -0.15 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | — | — | — | — | — | — | — | — | — | 1.25 | 75.32 |
| P/B Ratio | 0.57 | 1.79 | 15.83 | 2.53 | 0.73 | 0.04 | — | 1.54 | 0.17 | 0.02 | 0.45 |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — | — | — | — | — | -55.87 | 8.05 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | — | — | 90.5% | -727.1% |
| Operating Margin | — | — | — | — | — | — | — | — | — | -6943.1% | -12406.1% |
| Net Profit Margin | — | — | — | — | — | — | — | — | — | -28670.5% | -12597.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -203.6% | -203.6% | -182.3% | -131.4% | -131.7% | -78.4% | — | -67.0% | -61.7% | -137.3% | -70.0% |
| ROA | -89.9% | -89.9% | -89.9% | -60.4% | -59.9% | -58.9% | -39.1% | -56.0% | -52.3% | -118.8% | -63.0% |
| ROIC | -352.0% | -352.0% | -507.5% | -254.4% | -439.6% | — | — | -5474.2% | -8335.1% | -47.8% | -82.3% |
| ROCE | -130.0% | -130.0% | -121.0% | -72.0% | -75.3% | -74.1% | -47.0% | -66.4% | -51.4% | -32.8% | -68.5% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.22 | 1.22 | 0.80 | 0.77 | 1.22 | 0.51 | — | 0.08 | 0.01 | 0.05 | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 0.07 | -0.78 | -0.69 | -0.50 | -0.92 | — | -0.99 | -1.00 | -1.12 | -0.41 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -125.87 | -125.87 | -30.80 | -19.35 | -21.07 | -21.08 | — | — | -201.81 | — | -124.52 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.50 | 2.50 | 2.21 | 4.29 | 4.53 | 3.44 | 6.15 | 5.68 | 8.50 | 4.82 | 8.82 |
| Quick Ratio | 2.50 | 2.50 | 2.21 | 4.29 | 4.53 | 3.44 | 6.15 | 5.68 | 8.50 | 4.82 | 8.82 |
| Cash Ratio | 2.33 | 2.33 | 2.13 | 4.17 | 4.29 | 2.59 | 5.84 | 5.07 | 7.92 | 16.43 | 8.66 |
| Asset Turnover | — | — | — | — | — | — | — | — | — | 0.01 | 0.01 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | 1275.64 | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $4M | $28M | $15M | $888378 | $291562 | $31210 | $913782 | $103136 | $1168 | $142879 |
Includes 30+ ratios · 14 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying TPST stock.
Tempest Therapeutics, Inc.'s current P/E ratio is -0.1x. This places it at the 50th percentile of its historical range.
Tempest Therapeutics, Inc.'s return on equity (ROE) is -203.6%. The historical average is -105.4%.
Based on historical data, Tempest Therapeutics, Inc. is trading at a P/E of -0.1x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.